Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of Age

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Acute Otitis Media; Pneumonia

Treatments: Other: Data collection

Study type: Observational

Funder types: Industry

Identifiers

NCT02567747

203127

Details and patient eligibility

About

The purpose of this study is to provide data on trends of morbidity due to Acute Otitis Media (AOM) (primary analysis) and morbidity and mortality due to pneumonia, and AOM related health care resources before and after the introduction of vaccination against pneumococcal disease within the Universal Mass Vaccination (UMV) in Colombia.

Enrollment: 1 patient

Sex: All

Ages: Under 59 months old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Children aged less than five years with record of acute otitis media (with ICD-10 codes: H65 to H66) AND/OR.
• Children aged less than five years with record of pneumonia (with ICD-10 codes: J13 to J18) AND/OR.
• Children aged less than five years with any ICD-10 codes for respiratory diseases (J00-J99).

Exclusion criteria

• Not applicable

Trial design

1 participants in 1 patient group

Study cohort

Description:

The Total population will include all subjects included in the study. Only aggregated information will be collected for these subjects.

Treatment:

Other: Data collection